Search

More Filters

Hidden H4 Anchor

Hidden H4 Anchor

Hidden H4 Anchor

20 results found for "tags:"AIM with Immunotherapy""
Sort By: 

Library Entry
International IO Essentials

AIM with Immunotherapy Foundation presents the availability of videos from experts in each region in which they share strategies to care for patients during the COVID-19 pandemic. Supported by an educational grant from Bristol-Myers Squibb, the International Resources were developed based on...

SITC Education's profile image
SITC Education
Added 05-18-2021
View Library
 
Year 2021 Resource-Sharing Partnerships AIM with Immunotherapy Source Collaborative Partner Modality Document Video Web Page

Library Entry
"Your Guide to Cancer Immunotherapy" - An AIM at Melanoma Foundation Resource

Immunotherapy is one of the latest types of treatment that is being used to treat cancer by stimulating one's immune system to prevent, control, and eliminate cancer. This video from AIM at Melanoma explains how your immune system works, how immunotherapy treatments works, as well as possible...

AIM at Melanoma's profile image
AIM at Melanoma
Added 11-18-2019
View Library
 
Year 2019 Therapeutic Effects Adverse Events Side Effects Resource-Sharing Partnerships AIM with Immunotherapy Cancer Research Biomarkers Source Collaborative Partner Disease Melanoma Skin Cancers User Type Patient Patient Advocate Modality Video

Library Entry
Living With Melanoma Symposium – An AIM at Melanoma Foundation Resource – 2019

One cannot help but feel scared and overwhelmed after receiving a melanoma diagnosis. The challenges that patients, caregivers, family members, and friends face can be daunting and can continue even after treatment has ended. Beginning in 2010, AIM at Melanoma began partnering with nationally...

AIM at Melanoma's profile image
AIM at Melanoma
Added 08-01-2019
View Library
 
Year 2019 Therapies Adoptive Cell Therapy Combination Therapy Immune Checkpoint ... Immunomodulators Ipilimumab Nivolumab Pembrolizumab Therapeutic Effects Adverse Events Side Effects Resource-Sharing Partnerships AIM with Immunotherapy Cancer Research Biomarkers Clinical Trials T cells Source Collaborative Partner Modality In Person Event Video Web Page Disease Melanoma User Type Patient Patient Advocate

Library Entry
Living With Melanoma Symposium – An AIM at Melanoma Foundation Resource – 2018

One cannot help but feel scared and overwhelmed after receiving a melanoma diagnosis. The challenges that patients, caregivers, family members, and friends face can be daunting and can continue even after treatment has ended. Beginning in 2010, AIM at Melanoma began partnering with nationally...

AIM at Melanoma's profile image
AIM at Melanoma
Added 08-01-2019
View Library
 
Year 2018 Therapies Adoptive Cell Therapy Combination Therapy Immune Checkpoint ... Immunomodulators Ipilimumab Nivolumab Pembrolizumab Therapeutic Effects Adverse Events Side Effects Resource-Sharing Partnerships AIM with Immunotherapy Cancer Research Biomarkers Clinical Trials T cells Source Collaborative Partner Modality In Person Event Video Web Page Disease Melanoma User Type Patient Patient Advocate

Library Entry
Living With Melanoma Symposium – An AIM at Melanoma Foundation Resource – 2017

One cannot help but feel scared and overwhelmed after receiving a melanoma diagnosis. The challenges that patients, caregivers, family members, and friends face can be daunting and can continue even after treatment has ended. Beginning in 2010, AIM at Melanoma began partnering with nationally...

AIM at Melanoma's profile image
AIM at Melanoma
Added 08-01-2019
View Library
 
Year 2017 Therapies Adoptive Cell Therapy Combination Therapy Immune Checkpoint ... Immunomodulators Ipilimumab Nivolumab Pembrolizumab Therapeutic Effects Adverse Events Side Effects Resource-Sharing Partnerships AIM with Immunotherapy Cancer Research Biomarkers Clinical Trials T cells Source Collaborative Partner Modality In Person Event Video Web Page Disease Melanoma User Type Patient Patient Advocate

Library Entry
Living With Melanoma Symposium – An AIM at Melanoma Foundation Resource – 2016

One cannot help but feel scared and overwhelmed after receiving a melanoma diagnosis. The challenges that patients, caregivers, family members, and friends face can be daunting and can continue even after treatment has ended. Beginning in 2010, AIM at Melanoma began partnering with nationally...

AIM at Melanoma's profile image
AIM at Melanoma
Added 07-31-2019
View Library
 
Year 2016 Therapies Adoptive Cell Therapy Combination Therapy Immune Checkpoint ... Immunomodulators Ipilimumab Nivolumab Pembrolizumab Therapeutic Effects Adverse Events Side Effects Resource-Sharing Partnerships AIM with Immunotherapy Cancer Research Biomarkers Clinical Trials T cells Source Collaborative Partner Modality In Person Event Video Web Page Disease Melanoma User Type Patient Patient Advocate

Library Entry
Living With Melanoma Symposium – An AIM at Melanoma Foundation Resource – 2015

One cannot help but feel scared and overwhelmed after receiving a melanoma diagnosis. The challenges that patients, caregivers, family members, and friends face can be daunting and can continue even after treatment has ended. Beginning in 2010, AIM at Melanoma began partnering with...

AIM at Melanoma's profile image
AIM at Melanoma
Added 07-31-2019
View Library
 
Year 2015 Therapies Adoptive Cell Therapy Combination Therapy Immune Checkpoint ... Immunomodulators Ipilimumab Nivolumab Pembrolizumab Therapeutic Effects Adverse Events Side Effects Resource-Sharing Partnerships AIM with Immunotherapy Cancer Research Biomarkers Clinical Trials T cells Source Collaborative Partner Modality In Person Event Video Web Page Disease Melanoma User Type Patient Patient Advocate

Library Entry
Triage and Management of Pyrexia

In this video, Lisa A. Kottschade, APRN, MSN, CNP, of the Mayo Clinic, discusses triage and management of pyrexia in patients receiving BRAF/MEK inhibitor therapy. Click here to watch "Triage and Management of Pyrexia" #Melanoma #Video #CollaborativePartner #AdverseEvents ...

AIM at Melanoma's profile image
AIM at Melanoma
Added 01-11-2019
View Library
 
Year 2019 Therapeutic Effects Adverse Events Side Effects Resource-Sharing Partnerships AIM with Immunotherapy User Type Clinician Patient Patient Advocate Registered Nurse Source Collaborative Partner Disease Melanoma Modality Video

Library Entry
Steps to Recognize and Manage Ocular AEs Associated with BRAF/MEK Inhibitor Therapy

In this video, Lisa A. Kottschade, APRN, MSN, CNP, of the Mayo Clinic, discusses the steps to recognize and manage ocular AEs associated with BRAF/MEK inhibitor therapy. Click here to watch "Steps to Recognize and Manage Ocular AEs Associated with BRAF/MEK Inhibitor Therapy" #Melanoma ...

AIM at Melanoma's profile image
AIM at Melanoma
Added 01-11-2019
View Library
 
Year 2019 Therapeutic Effects Adverse Events Side Effects Resource-Sharing Partnerships AIM with Immunotherapy User Type Clinician Patient Patient Advocate Registered Nurse Source Collaborative Partner Disease Melanoma Modality Video

Library Entry
Management of Cardiac AEs Associated With BRAF/MEK Inhibitor Therapy

In this video, Lisa A. Kottschade, APRN, MSN, CNP, of the Mayo Clinic, discusses the management of cardiac AEs associated with BRAF/MEK inhibitor therapy. Click here to watch "Management of Cardiac AEs Associated with BRAF/MEK Inhibitor Therapy" #Melanoma #Video #CollaborativePartner...

AIM at Melanoma's profile image
AIM at Melanoma
Added 01-11-2019
View Library
 
Year 2019 Therapeutic Effects Adverse Events Side Effects Resource-Sharing Partnerships AIM with Immunotherapy User Type Clinician Patient Patient Advocate Registered Nurse Source Collaborative Partner Disease Melanoma Modality Video
Showing 1-10 of 20 results